{"name":"Tetra Discovery Partners","slug":"tetra-discovery-partners","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BPN14770","genericName":"BPN14770","slug":"bpn14770","indication":"Treatment of autoimmune diseases such as rheumatoid arthritis","status":"phase_2"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"BPN14770/ zatolmilast","genericName":"BPN14770/ zatolmilast","slug":"bpn14770-zatolmilast","indication":"Cognitive impairment associated with schizophrenia","status":"phase_3"}]}],"pipeline":[{"name":"BPN14770","genericName":"BPN14770","slug":"bpn14770","phase":"phase_2","mechanism":"BPN14770 is a small molecule inhibitor of the PI3K delta subunit.","indications":["Treatment of autoimmune diseases such as rheumatoid arthritis"],"catalyst":""},{"name":"BPN14770/ zatolmilast","genericName":"BPN14770/ zatolmilast","slug":"bpn14770-zatolmilast","phase":"phase_3","mechanism":"BPN14770 is a phosphodiesterase 4D (PDE4D) inhibitor that increases intracellular cAMP levels to enhance cognitive function and reduce neuroinflammation.","indications":["Cognitive impairment associated with schizophrenia","Alzheimer's disease"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPS1ZFNHhwTFB4SXJwcF92MFd5VlNZdXFWM2hoYWU4OFlDdlN5X3VkVkhHUHVmenBZQ2xYY2h3Z3ZYUXZNSXFjd2FLb1h2NUxJYnhlc0F4TlNobG9zaWtyLWpLRFpRQk5LUC1qOHhxNnhZaW54MmFZZ3J2Q2FncnRwN051cVVjWGRwN21NenR6RVAzYmNRWEVrOV9GbVhjTmZ5V0RtNmJVdk80WkhnRUxpY1E1YTBDX3dKM05JYllIUHpDcmhVOUlfZ2VkMjYzRTlYaldBSDNNM0dWTGdrZ1JobkN6MHdGaGk2OFN0SUFTLVI0RjFxNnFFV0l1WUg0Z3lKMVRCUVZlVlE?oc=5","date":"2026-01-14","type":"pipeline","source":"prnewswire.com","summary":"TetraScience Appoints Matt Studney as Chief Customer Officer, Signaling Industry Shift Toward Platform-Based Scientific AI - prnewswire.com","headline":"TetraScience Appoints Matt Studney as Chief Customer Officer, Signaling Industry Shift Toward Platform-Based Scientific ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOZVh3QW9SRmFKejZlZ1RqNkR4T3FFa3FPUnRpanUwZU1ZUWZqTDY3ODRYU3JhbFNiSEJPYzJWMDFFbkFadFEzdkRfOGh0Um95cVRHYm55UFVyci1NQnVqZE04aHRBZmV6QWlTYm94RXYxR0Nja0VIamxjalpVMERmc1VjOFRSWDk3a1RiRDJIRktnNHBtLWwtaDBVRzRWMGRPNkRjTVBYU1hsaW92S0VaUkFTaS1Ta0tpN1E?oc=5","date":"2026-01-12","type":"pipeline","source":"Fierce Biotech","summary":"Thermo Fisher Scientific teams up with Nvidia, TetraScience for next-gen AI workflow projects - Fierce Biotech","headline":"Thermo Fisher Scientific teams up with Nvidia, TetraScience for next-gen AI workflow projects","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQcHdRYllJVXB5ckJmZThxYlJMVk9WN2k1NXVzWUxIVThBeG1vTHVKVjlwbnI1WVFkQzU0NWpQRHRnWXZ2VHVvTTFrcVpOelVVU01xbXA0dlM2ejdMSVhIUW5OemQxTUEwS1dTd09qLWFHc1ZnclA1T0QzMDJCVldLTjF1bw?oc=5","date":"2025-10-28","type":"pipeline","source":"NVIDIA Blog","summary":"Lilly Deploys World’s Largest, Most Powerful AI Factory for Drug Discovery Using NVIDIA Blackwell-Based DGX SuperPOD - NVIDIA Blog","headline":"Lilly Deploys World’s Largest, Most Powerful AI Factory for Drug Discovery Using NVIDIA Blackwell-Based DGX SuperPOD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNWZFZzBacFNpNTc0a3NNOE1zUnkxVjBYdWZkTVNTdUZMbHFYN3phU1dYUkxIN29BNHJPUWlIQzEwSF9VaHZoTlFuekpZVjJTREJERC1UWVhHdWhqeGp0QXpyVEtPWm5aRXgwbmRLUzlkR2JfMThrLXdLOUpCWm1UQzFFdVFlaUxaeDNnOXhiZ2Q0cjVqUWlBYUtR?oc=5","date":"2025-10-21","type":"pipeline","source":"National Institute of Neurological Disorders and Stroke (.gov)","summary":"Translational Research Success Stories - National Institute of Neurological Disorders and Stroke (.gov)","headline":"Translational Research Success Stories - National Institute of Neurological Disorders and Stroke (.gov)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQLUZSRHBDUmQ3Z0RGTjdhVXhKQlN5bFEwbC1hNHEyNU9XVVVnR2hweWVsSkpQbHprRGdDUWZuTXFzbjRWYlZ4U2lOemZhMTB5RUNHTGpYNDJudTY2Q2xfMEhGR2tGRzBYMHRVQTRGemd2emhzbTZlVjJ5R1p0cVZkVmFqUDc2aDNjdmJOaENIUEFURjVjek1jb0xfcG5FSE5kRk1Td1BoT0FCaUNE?oc=5","date":"2023-12-15","type":"trial","source":"Amazon Web Services","summary":"Automated genomic data processing with AWS HealthOmics & TetraScience - Amazon Web Services","headline":"Automated genomic data processing with AWS HealthOmics & TetraScience","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOeldvak1EMnR4MmwyTWpuRC0xSjQ3VTY5QzVrdmdQWlQ3TTlnY0VlVXRScmpNVUVDaTN2YTQ5WW15a1VWYlVFWmx3VHdfbm1ETU1LMllCNV96bm1oLTE3Ri1qdktCMzU3SThPeFpHOTBUQW1mNUFtcEE2dFdpNldkWVNWV0M?oc=5","date":"2022-09-07","type":"deal","source":"Pharmaceutical Technology","summary":"Tetra and Cellvera partner to develop oral Covid-19 treatment - Pharmaceutical Technology","headline":"Tetra and Cellvera partner to develop oral Covid-19 treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxObEEtOGxxSkEyS0N0V19idmU3ajNNcGlScW1GTDE1VDRvQll6bnFzbUNaTHo4Z2ZXaElXc3pUNkFqQ3FnTnh6TV96S3Z6Z0VzZ2JMZGl1UEpPSlVFUXlDUzRFZWoyenFOMF9UNkNNYVAzSjRuM1ROWk84dGQ4MGJpYlVXQW56QmFrbWJFUGFqWVF0SzV2cFotQ1ZvSE42MFVfd1A5QmlHZmNzRTdCVlduOG9rX1hUMGlPUm9HNmFfNHpIZk4y?oc=5","date":"2022-08-16","type":"pipeline","source":"Labiotech.eu","summary":"Tetro Bio-Pharma enters subscription agreement following advice from Alpha Blue Ocean - Labiotech.eu","headline":"Tetro Bio-Pharma enters subscription agreement following advice from Alpha Blue Ocean","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxQNDZGd2FMcE9mMTNsM3pHR2hLRHYySEpEMExGa3EwWXNKNDBQbW5qMFVscjFGdHFkbEJmWDJlN2hoRVV5X0R0ZENGbUJBRVBOOFdyWHFtY05EejVWeGpncDNtX2tkTkFkclhqUHZnc0dtZFQ0Z1liNlc2NEoyS0hQTTdnWmdWaUtERUFjTno4QVJSQjQ4Z1hiNi0zYzhsLS11YUdWeHRBY295Yzg1clQ4M2l2WFVSbzVkV0FoeEpoTHJhUUpnV1BTMDF5Qjh6R2JacGZXM0tMcEJWT3pQY3pSUms4ai00S3h3Y0JkUXRrQ0I4LWh2dUdPT0NXWWNpTWJLQUJvZVJpYXo5aEszMXZRRk1YSFNWbEppRFdjN0NYQzNUalduV1hiaw?oc=5","date":"2022-07-12","type":"regulatory","source":"businesswire.com","summary":"Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug - businesswire.com","headline":"Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNenc2bUFLdWJhMDNHclRWX3VrT2lzZVNzT2hBSzZfbzYtamdrRGM4c2pVSXFmNXFfd0RjRUh1dFhpMDF1bnRiRGZOSXpibVlGYkV5MTRiLUIzZC1yVjEzS0liaEJtUlZjcUdZbFFad3VTUUtOS3owTTA1b09YNF8zeDZQOFBuZE5Na3lMX2hhRDU3bGhyN1pTdkFXMVhzTElzdTgtMzM3R2N1Zw?oc=5","date":"2022-06-06","type":"regulatory","source":"BioSpace","summary":"Tetra Bio-Pharma Opens New Subsidiary in Australia and Provides Regulatory Update - BioSpace","headline":"Tetra Bio-Pharma Opens New Subsidiary in Australia and Provides Regulatory Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPbmZPaWhRSDFNUFpfZ296Y09LVFhsUU5OUmNILXZsVGV4eVNDSk8yYzdjOF9aLVBMUmtnLVpSOFQxOHJ6S01xdWttTlVhT3NyZWEzTktqOENRTlZlWnF6QnQ1N3lIaTU3UGZibzJjOVo3bzhQQnQxWWVrQjZUejVjNTREYjk0eTZndlRLeXg3U1VUNENqWjVISnVRYTd0RW9BZ3lNU1VWeU83YW9CcFVIOQ?oc=5","date":"2021-04-16","type":"trial","source":"fiercehealthcare.com","summary":"TetraScience scores $80M series B investment, rolls out open R&D data cloud - fiercehealthcare.com","headline":"TetraScience scores $80M series B investment, rolls out open R&D data cloud","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNOUhtZ3JySTVRUHBCUGdGalpLYjhpTWFiNHZBWDlOSG1SejdxdEtFOGpmUU5POVVBSkc1ZzQ0NERfOG95bURfcnoyX3hSY0NJbGhCaVpaSTBreXpZdjNLaERaN195c2d0WjdOTHNDTDJucmRMLW1ncXJIWVpGVWdELWhYQ2NxZmNqY0ZjU3VkX0l3TEFwd0IyMWtwSTRTQ191akFQNjVwOGpVamJWNFUzSjc0a3RSQ2JEcXlBNnRpbk9fc3piWGxZ?oc=5","date":"2019-03-10","type":"deal","source":"Crain's Detroit","summary":"Grand Rapids-based Tetra Discovery Partners strikes deal to test Alzheimer's, Fragile X treatment - Crain's Detroit","headline":"Grand Rapids-based Tetra Discovery Partners strikes deal to test Alzheimer's, Fragile X treatment - Crain's Detroit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQTTE2MEpqd3pIVXZ5Z19NRlFocXo5MW5UbDhpQWZ6Z0lSU2VVcTRKd2k0WTJTZDJfSEFZd0w4VGJEZzNWcDlPbUg0dklpNU85UURwUDNJYlhLSTVYTnFTejhmc2xWQ2FpTTZSanVTZFA2VjBaZDZka0ZJNFdkdko5ejB3NEJvNThJb1RqSUY3dmN1cUVCMEpHVnVrc1A3aWsxVzZn?oc=5","date":"2018-12-19","type":"pipeline","source":"Fierce Biotech","summary":"Tetra, Shionogi ink $40M pact on PDE4 drug for Alzheimer’s, fragile X - Fierce Biotech","headline":"Tetra, Shionogi ink $40M pact on PDE4 drug for Alzheimer’s, fragile X","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"phase_3":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}